Evoke Pharma
(NASDAQ) EVOK
Evoke Pharma Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$14.42M
Net Income (TTM)
$5.23M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
EVOK News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Evoke Pharma
Industry
Pharmaceuticals
Sector
Health CareEmployees
3
CEO
Matthew J. D'Onofrio, MBA
Website
www.evokepharma.comHeadquarters
Solana Beach, CA 92075, US
EVOK Financials
Key Financial Metrics (TTM)
Gross Margin
97%
Operating Margin
-36%
Net Income Margin
-36%
Return on Equity
-1%
Return on Capital
-2%
Return on Assets
-33%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$9.89M
Operating Income
$5.20M
EBITDA
$353.31K
Operating Cash Flow
$5.46M
Capital Expenditure
$0.00
Free Cash Flow
$5.46M
Cash & ST Invst.
$13.60M
Total Debt
$5.16M
Evoke Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$4.28M
+61.4%
Gross Profit
$4.18M
+64.0%
Gross Margin
97.62%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
3
N/A
Net Income
$1.16M
+11.9%
EBITDA
$1.03M
+13.2%
Quarterly Fundamentals
Net Cash
$6.46M
+2.0%
Accounts Receivable
$3.19M
+57.7%
Inventory
$599.91K
+21.6%
Long Term Debt
$46.38K
N/A
Short Term Debt
$5.07M
+1.3%
Return on Assets
-33.39%
N/A
Return on Invested Capital
-1.52%
N/A
Free Cash Flow
$521.96K
+36.2%
Operating Cash Flow
$521.96K
+36.2%